Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
Third Harmonic Bio, Inc. (THRD)
Company Research
Source: GlobeNewswire
U.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results expected during 1H’25 Strengthened leadership team with the appointment of Christopher J. Dinsmore, Ph.D., to Chief Scientific Officer, Dennis Dean, Ph.D., to Chief Non-Clinical Development Officer, and the promotion of Jennifer Dittman to Chief Development Operations Officer Strong financial position with cash and cash equivalents totaling $262.8 million as of March 31, 2024 SAN FRANCISCO, May 15, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, today announced financial results for the first quarter March 31, 2024, recent business updates, and anticipated milestones. As part of its business update, the Company announced U.S. FDA clearance of its Investiga
Show less
Read more
Impact Snapshot
Event Time:
THRD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
THRD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
THRD alerts
High impacting Third Harmonic Bio, Inc. news events
Weekly update
A roundup of the hottest topics
THRD
News
- Third Harmonic Bio (NASDAQ:THRD) Is In A Strong Position To Grow Its Business [Yahoo! Finance]Yahoo! Finance
- Third Harmonic Bio to Participate in Upcoming Investor Conferences in SeptemberGlobeNewswire
- Third Harmonic Bio to Participate in Upcoming Investor ConferencesGlobeNewswire
- Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business UpdateGlobeNewswire
THRD
Earnings
- 5/15/24 - Beat
THRD
Sec Filings
- 9/27/24 - Form SC
- 9/20/24 - Form 4
- 9/20/24 - Form 4
- THRD's page on the SEC website